A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion F Protein Is More Effective than RSV for Boosting a Primary Immunization with RSV

Live-attenuated pediatric vaccines for intranasal administration are being developed for human respiratory syncytial virus (RSV), an important worldwide pediatric respiratory pathogen that lacks a licensed vaccine or suitable antiviral drug. We evaluated a prime-boost strategy in which primary immun...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Virol
Autors principals: Liang, Bo, Matsuoka, Yumiko, Le Nouën, Cyril, Liu, Xueqiao, Herbert, Richard, Swerczek, Joanna, Santos, Celia, Paneru, Monica, Collins, Peter L., Buchholz, Ursula J., Munir, Shirin
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2020
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7944453/
https://ncbi.nlm.nih.gov/pubmed/33115876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01512-20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars